Serum resistin levels in Syrian obese patients with diabetes mellitus type II

Saudi Medical Journal

Volumn 28, Issue 12, 2007, Pages 1890-1894

  Al Sari, Ismail E ^a   Al Quobaili, Faizah A ^a   Kabalan, Younes M ^a  

^a DAMASCUS UNIVERSITY   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; RESISTIN; TRIACYLGLYCEROL; UREA; RETN PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BIOCHEMISTRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; SYRIAN ARAB REPUBLIC; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; RESISTIN; SYRIA;

EID: 41149087390     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
2. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 2001; 98: 502-506.
3. Flier JS. Diabetes. The missing link with obesity? Nature 2001; 409: 292-293.
4. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88: 5452-5455.
5. Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004; 339: 57-63.
6. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin actiokn on glucose production. J Clin Invest 2003; 111: 225-230.
7. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 2003; 285: E106-E115. Epub 2003 Mar 4.
8. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114: 224-231.
9. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Raistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46-47.
10. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407.
11. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476.
12. Fain JN, Cheema PS, Bahouth SW, LLoyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commmun 2003; 302: 674-678. Erratum in: Biochem Biophys Res Commun 2003; 302: 917-918.
13. Friedwald WT, Levy RI, Fredrickson, DS. Estimation of the concentration of low density lipoprotein cholesterol without the use of the preparation ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Yang RZ, Huang Q, Xu A, McLenithan JC, Eisen JA, Shuldiner AR, et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 2003; 312: 866. Eison Jonathan A [corrected to Eisen Jonathan A].
15. McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, et al. Resistin and type 2 diabetes regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098-6106.
16. Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol 2005; 4: 10.
17. Lu HL, Wang HW, Wen Y, Zhang MX, Lin HH. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World Gastroenterol 2006; 12: 1747-1751.
18. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001.
19. Chanchay S, Tungtronchitr R, Harnroongroj T, Phontat B, Rungseesakorn O, Paksanont S, et al. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int J Vitam Nutr Res 2006; 76: 125-131.
20. Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabtes mellitus. Scand J Clin Lab Invest 2007; 67: 215-225.
21. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, et al. Increased serum resistin levels in patients wity type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 2005; 42: 104-109.
22. Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Metabolism 2006; 55: 1495-1499.
23. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J clin Endocrinol Metab 2004; 89: 1844-1848.
24. Banerke PR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, et al. Regulation of fasted blood glucose by resistin Science 2004; 303: 1195-1198.
25. Qi Y, Nie Z, Lee YS, Singhal NS, Scherer PE, Lazar MA, et al. Loss of resistin improves glucose homeostasis in in leptin deficiency. Diabetes 2006; 55: 3083-3090.
26. Al-Harithy RN, Al-Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus, Ann Saudi Med 2005; 25: 283-287.
27. Tokuyama Y, Osawa H, Ishizuka T, Onuma H, Matsui K, Egashira T, et al. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus Metabolism 2007; 56: 693-698.
28. Smith SR, Bai F, Charbonneau C, Janderová L, Argyropoulos G. A promoter genotype and oxidation stress potentially link resistin to human insulin resistance. Diabetes 2003; 51: 1611-1618.
29. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848-4856.
30. Pfützner A, Langefeld M, Kunt T, Löbig M, Fostst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003; 49: 571-576.
31. Gerber M, Boettner A, Seidel B, Lammert A, Bär J, Schuster E, et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005; 90: 4503-4509. Epub 2005 May 31.
32. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007; 156: 279-284.